NewsRoom Articles - Page 139 of 207

TuesdayAug 17, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Welcomes Digital Technology Expert in Development of Doctor-Patient SaaS Tech

Canada-based life sciences company Mind Cure Health is pursuing innovative technology and research solutions to improve mental health through technology The company is focused on developing digital therapeutics technology and researching psychedelic compounds The company’s proprietary software-as-a-service (SaaS) platform iSTRYM is designed to increase transparency and awareness between patients and therapists On the research side, Mind Cure Health is also manufacturing synthetic ibogaine and currently determining the commercialization potential of two different pathways for production Mind Cure Health recently announced an agreement with experienced clinical psychologist Dr. Ken Weingardt to guide iSTRYM toward near-term commercial deployment A growing number of…

TuesdayAug 17, 2021 9:00 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces New Cooperative and Partnership Agreements, and further Strengthens Board of Directors

Cooperation and partnership discussions: AnPac Bio has reported major corporations in the medical industry include Roche Pharmaceuticals China and Advanced Life Therapeutics Co., Ltd AnPac Bio holds 40% minority equity in Advanced Life Therapeutics, performing contract R&D on integrated circuit-based components for cancer treatment medical devices AnPac Bio’s board now includes Mr. Chao Feng who has global fortune 500 Companies’ managerial experience as independent director effective July 19, 2021 AnPac Bio-Medical Science (NASDAQ: ANPC), an innovative thought leader and biotechnology company focused on early screening and cancer detection by developing, distributing, and deploying accessible early disease detection devices, announced a…

TuesdayAug 17, 2021 9:00 am

Brain Scientific Inc.’s (BRSF) Technology Could Be Part of the Solution as New Research Finds that Neurological Consequences of COVID-19 Could be the Norm Rather than Exception

It has become known that COVID-19 patients can present with neurological symptoms, but new comprehensive cross-country study indicates that it could be more prevalent than previously thought This could represent enormous challenge to healthcare as it needs to prepare for immediate and longer-term rehabilitation care of these patients Brain Scientific is committed to remaining at forefront of brain diagnostics, potentially offering solution to higher need for neurological care of COVID-19 patients Brain Scientific (OTCQB: BRSF), a commercial-stage health care company on a mission to modernize brain diagnostics, could be the one offering solution to the rising challenge global healthcare systems…

MondayAug 16, 2021 3:00 pm

How Technology Can Be Useful in Mental Health Treatment

We have seen the conversation on mental health and its importance grow recently past as more people share their experiences and stories of the challenges they’ve faced as they dealt with their own mental health disorders. This openness has made it easier for people who may be struggling with mental health issues to seek help, unlike in the past, when mental illnesses such as depression were treated as a taboo subject. As society becomes more enlightened about mental illnesses and the impact they have, not only on an individual’s life but also society at large, technology is also being used…

MondayAug 16, 2021 12:04 pm

DGE’s Blockchain Pharma & Life Sciences Summit To Bring Together Industry Leaders For A Consolidated Global Blockchain Management System

Medical professionals are invited to attend DGE’s Blockchain Pharma & Life Sciences Summit on August 23-24, 2021 to learn successful strategies of successfully using the decentralized technology to boost trust and improve transparency throughout the life science ecosystem including regulators, contract manufacturers, physicians, and patients. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The world-class event company is an industry leader meeting the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries. Attendees will discover the various areas that blockchain technology can be used in including clinical research…

FridayAug 13, 2021 2:36 pm

Rare Cannabinoids Slowly Revolutionizing the Pharmaceutical Industry

Cannabis is now legal for recreational use in 18 states and legal for medicinal use in 36 states across the country. As the plant gains more popularity, so do some of its products, the most popular ones being THC and CBD, which are cannabinoids. Cannabinoids are compounds found in the cannabis plant. Other cannabinoids found in the cannabis plant include tetrahydrocannabivarin (“THCV”), cannabinol (“CBN”) and cannabigerol (“CBG”), among others. These rare cannabinoids don’t possess THC’s psychoactive properties and have been found to be more potent in comparison to CBD. Forecasts show that by the year 2029, the international market for…

FridayAug 13, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Bolsters its Advisory Board With The Appointment of Jerry White

Mind Cure Health Inc. announced Jerry White’s appointment into the company’s advisory board Mr. White brings a wealth of experience from his years of powering global movements and working with key leaders and personalities around the world MINDCURE forecasts that with Mr. White’s addition to the board, the company will be well-positioned to achieve bigger and better goals, all while working towards its overall vision of building mental wealth globally Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) announced that it has appointed Jerry White as an advisor to the company. Mr. White would be an excellent addition to…

FridayAug 13, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Shares Insights on the Psychedelics Space on The Dealmaker Podcast

Mr. Greg McKee, CEO of Tryp Therapeutics, appeared on The Dealmaker Podcast to share insights on the company and the psychedelics industry During the interview, he discussed the potential of psychedelics in the treatment of PTSD and other mental disorders Greg also shared the challenges that the industry is facing currently, mostly to do with legislation McKee also shared how people can help the company and the industry by pushing for the decriminalization of psychedelics and taking part in clinical trials On August 2, 2021, the Dealmaker Podcast posted an interview with Greg McKee, the Chief Executive Officer (“CEO”) of…

ThursdayAug 12, 2021 11:33 am

Anpac Bio Continues Growth Trajectory

In recent years, advances in technology have led to demand for early cancer testing and screening methods that are less invasive and lower cost. Insurance companies have accepted that traditional testing methods are labor intensive and are not ideal as the first line of defense when screening and diagnosing cancer. This has opened a multi-billion-dollar market opportunity in discovering new solutions to tackle cancer and disease testing outside of traditional diagnostics that have been used for generations without any major upgrades or breakthroughs. AnPac Bio-Medical Science Co., Ltd. (ANPC.US), a biotechnology company focused on early cancer screening and detection as…

ThursdayAug 12, 2021 10:48 am

Fluorescent Imaging Agent May Allow for Better Cervical Cancer Detection

Recently conducted research has discovered that cervical cancer can be detected by clinicians using a handheld microscope and a topical fluorescent imaging agent dubbed PARPi-FL. This imaging technique targets the PARP1 enzyme, which is overexpressed in this type of cancer. It has the potential to revolutionize cervical cancer biopsies and screenings. Cervical cancer is the fourth most common cancer in women. Data shows that in 2018, nearly 600,000 women were diagnosed with this cancer type globally, with roughly 310,000 of them succumbing to the disease. Almost 99% of cervical cancer cases are caused by human papilloma virus (“HPV”), which can…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Welcomes Digital Technology Expert in Development of Doctor-Patient SaaS Tech

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces New Cooperative and Partnership Agreements, and further Strengthens Board of Directors

Brain Scientific Inc.’s (BRSF) Technology Could Be Part of the Solution as New Research Finds that Neurological Consequences of COVID-19 Could be the Norm Rather than Exception

How Technology Can Be Useful in Mental Health Treatment

DGE’s Blockchain Pharma & Life Sciences Summit To Bring Together Industry Leaders For A Consolidated Global Blockchain Management System

Rare Cannabinoids Slowly Revolutionizing the Pharmaceutical Industry

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Bolsters its Advisory Board With The Appointment of Jerry White

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Shares Insights on the Psychedelics Space on The Dealmaker Podcast

Anpac Bio Continues Growth Trajectory

Fluorescent Imaging Agent May Allow for Better Cervical Cancer Detection

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search